v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended 15 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Mar. 31, 2026
Cash flows from operating activities:          
Net loss $ (4,020,831) $ (308,081) $ (8,021,235) $ 4,103,067  
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of debt discount 450,366 124,058 2,199,320 94,168  
Shares issued for services 2,190,730 58,125 772,067 6,125  
Shares issued for forbearance fee     13,226,926  
Default penalties and interest on notes payable     1,276,447  
Change in fair value of warrant liability (208,929) (234,195) (803,680) 397,553  
Change in fair value of earnout shares liability (1,039,282) (1,053,084) (18,731,514)  
Loss on extinguishment of debt 6,929 760,302  
Change in assets and liabilities:          
Royalty receivable     (7,138)  
Other receivable     3,196 17,224  
Prepaid expenses and other current assets (107,579) 211,563 238,369 (801,386)  
Employee advance 7,500 (7,500)  
Accounts payable and accrued expenses 307,306 580,053 960,698 41,893  
Accrued expenses - related party (226,172) 252,830 (88,350)  
Accrued interest payable - related party 112,084 13,612 219,226 57,795  
Net cash used in operating activities (1,488,596) (594,147) (3,210,182) (1,676,499)  
Cash flows from investing activities:          
Purchase of property, plant and equipment (119,797) (8,050)  
Cash acquired with merger     2,537  
Acquisition costs     (361,643)  
Net cash used in investing activities (119,797) (8,050) (359,106)  
Cash flows from financing activities:          
Proceeds from notes payable to related party 200,000 2,800,000 500,000  
Repayment of notes payable to related party (30,000) (800,000) (123,972)  
Repayment of due to investor     (1,000,000)  
Proceeds from convertible notes payable     1,250,000 2,600,000  
Repayment of convertible notes payable (110,000) (500,000)  
Proceeds from financing payable     464,000 663,582  
Repayment of financing payable (139,200) (193,390) (663,582)  
Proceeds from the at-the-market offering 1,855,101 25,000  
Net cash provided by financing activities 1,575,901 6,610 2,550,418 2,664,610  
Net change in cash (32,492) (587,537) (667,814) 629,005  
Cash at beginning of period 68,000 735,814 735,814 106,809 $ 735,814
Cash at end of period 35,508 148,277 68,000 735,814 $ 35,508
Supplemental disclosures of cash flow information:          
Cash paid for interest  
Cash paid for taxes 200  
Supplemental non-cash information          
Common shares issued as financing incentive     1,437,375  
Common shares issued from conversion of preferred series C shares     30,638,517  
Common shares issued from settlement of accounts payable 321,960      
Common shares issued for services but not yet vested 1,635,230      
Common shares issued from conversion of convertible notes payable $ 383,719 3,750,000  
Warrants issued with convertible notes payable     547,151  
Reversal of excise tax liability     2,348,302  
Net assets and liabilities assumed in the merger     (25,236,215)  
Common shares cancelled per forfeiture agreement     85  
Shares issued to related party applied directly against accumulated deficit     35,000  
Discounts on notes payable applied directly against accumulated deficit     $ 14,087